News Archive

A Hollings clinical trial is testing the impact of changing the order of treatments for metastatic prostate cancer patients.

Dr. Elizabeth Hill has joined MUSC Hollings Cancer Center as the new director of the Biostatistics Shared Resource.

A portion of the proceeds from this year's Head for the Cure Charleston 5K will support brain cancer research at Hollings.

Marine veteran Tony Pesavento survived multiple battles with larynx cancer and credits a clinical trial with saving his life.

Hollings researchers are testing a new prostate cancer drug that may help patients who stop responding to standard treatments.

In honor of Cervical Cancer Awareness Month, Dr. Jerlinda Ross shares what she wishes more women knew about cervical cancer.

Even during the pandemic, getting routine cancer screenings is important because early detection is key to better treatment outcomes.

Hollings experts offer six tips for adopting lifestyle changes that can help lower your cancer risk and improve your health.

It turns out vials of the Pfizer-BioNTech COVID-19 vaccine – each of which was supposed to contain five doses – has as many as one or two more in them.

MUSC received its first shipment of the Pfizer COVID-19 vaccine on Tuesday. In less than three hours of receipt it was going in the arms of front line workers.